$VXRT Don’t Stop Believin’ 19 Hideki Hasegawa, Director of the WHO Collaborating Centre on Influenza in Tokyo, Director of the National Influenza Center in Japan. Dr.Hasegawa has been studying the MUCOSAL vaccine and MUCOSAL adjuvant development for influenza, and the character of secretory IgA antibody in the upper respiratory system. Ziad Memish, Head of research department at Prince Mohammed Bin Abdulaziz hospital, Ministry of Health. Professor at the College of Medicine in Alfaisal University, Riyadh, Saudi Arabia; and Adjunct Professor in the Hubert Department of Global Health, Rollins School of Public Health, EMORY University, Georgia. Professor Elizabeth Miller, former Head of Immunisation at Public Health England and is now a professor at the London School of Hygiene and the Sackler School of Public Health at Tel Aviv University. Assesses COVID vaccines that are candidates for inclusion in WHO’s efficacy trials (SOLIDARITY).